News tagged ‘LungCancer’ clear
- By mapping the interlocking structures of small molecules and mutated
protein "receptors" in non-small cell lung cancer (NSCLC) cells,
scientists at Dana-Farber and their colleagues have energized efforts to
design molecules that mesh with these receptors, potentially
interfering with cancer cell growth and survival.
Tags: LungCancer
- An international research team, led by investigators from the
Massachusetts General Hospital (MGH) Cancer Center and Dana-Farber
Cancer Institute, has found a new way that some lung tumors become
resistant to treatment with targeted therapy drugs like Iressa and
Tarceva.
Tags: LungCancer
- A widely used diabetes drug dramatically boosted the potency of
platinum-based cancer drugs when administered together to a variety of
cancer cell lines and to mice with tumors, scientists from Dana-Farber
report.
Tags: LungCancer, OvarianCancer
- Blacks in the United States are less certain than whites about recommendations to prevent lung cancer and are more fearful of having symptoms evaluated — beliefs that may keep them from seeking timely treatment for the disease, researchers from Dana-Farber Cancer Institute reported at the American Society of Clinical Oncology's annual meeting in Chicago.
Tags: LungCancer, Disparities
- Collaborating scientists in Boston and North Carolina have found that a
particular gene can block key steps of the lung cancer process in mice.
The researchers report in the journal Nature that LKB1
is not only a "tumor-suppressor" gene for non-small cell lung cancer in
mice, it also may be more powerful than other, better-known
suppressors.
Tags: BasicResearch, LungCancer
- A collaborative study involving Dana-Farber researchers has
unearthed a variety of genetic alterations in lung tumors, more than
doubling the number already linked to the disease.
Tags: Genomics, LungCancer
- Researchers at Boston cancer centers have found that a combination of
kinase inhibitors may lead to future treatments for lung cancer, colon
cancer, and prostate tumors.
Tags: KinaseInhibitor, LungCancer
Researchers have halted non-small cell lung tumors resistant to Iressa
and Tarceva with a newly constructed compound that may also have fewer
side effects.
Tags: DrugResistance, LungCancer
- Identifying patients with a specific gene mutation that enables drug
resistance, and treating them with a combination of drugs, may produce
longer remissions, say researchers.
Tags: EGFR, LungCancer
- The study found African Americans are more likely to hold perceptions that could interfere with prevention and treatment and indicate a need for improved public health communication about lung cancer.
Tags: BasicResearch, LungCancer